---

A comparative study of the efficacy of preoperative loteprednol versus flurbiprofen in cataract surgery

---

Original Article

Author Details : Tek Chand*, Arvind Chauhan

Volume : 6, Issue : 4, Year : 2020

Article Page : 581-586

https://doi.org/10.18231/j.ijceo.2020.122

Suggest article by email

Get Permission

---

Abstract

Purpose: To evaluate the efficacy and cost-effectiveness of preoperative loteprednol versus flurbiprofen, when combined with moxifloxacin in maintaining intraoperative mydriasis and reducing postoperative complications.
Materials and Methods: 200 cataract patients were divided into 2 groups. Group 1 receiving preoperative Flurbiprofen(0.03%) with moxifloxacin(0.5%) and Group 2 receiving Loteprednol(0.5%) with moxifloxacin(0.5%), three times a day 24 hrs prior to cataract surgery,followed by postoperative loteprednol(0.5%) and moxifloxacin(0.5%) in both groups. Intraoperative mydriasis and post operative complications were analysed. Patients were followed up on day 1, 1 week, 3 weeks and 7 weeks. Parameters
evaluated included inflammation, pain, corneal edema, anterior chamber reaction (including cells and flare), intraocular pressure, CME.
Results: Intraoperative mydriasis obtained in both the groups was comparable with no significant difference. Postoperative visual outcome was also comparable but postoperative inflammation was slightly more in Group 1 (p <0> Conclusion: This hospital based study in western Rajasthan revealed Loteprednol to be equally potent as flurbiprofen in maintaining intraoperative mydriasis along with significant reduction of postoperative complications while maintaining cost effectiveness and compliance as a single eye drop was used before and after surgery, with no steroid related complications.

Keywords: Flurbiprofen, Intraoperative mydriasis, Loteprednol, Postoperative complications.

How to cite : Chand T , Chauhan A , A comparative study of the efficacy of preoperative loteprednol versus flurbiprofen in cataract surgery. Indian J Clin Exp Ophthalmol 2020;6(4):581-586

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.